Reporter Cell Lines
GemPharmatech's Luciferase-modified cell lines, comprising solid and hematological malignancies, provide a wealth of tumor models for evaluating CAR-T efficacy.
GemPharmatech's Luciferase-modified cell lines, comprising solid and hematological malignancies, provide a wealth of tumor models for evaluating CAR-T efficacy.